Heparanase as mediator of angiogenesis: mode of action
Top Cited Papers
Open Access
- 29 May 2001
- journal article
- fj express-summaries
- Published by Wiley in The FASEB Journal
- Vol. 15 (9), 1661-1663
- https://doi.org/10.1096/fj.00-0895fje
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Culture and Sport
- Deutsches Krebsforschungszentrum
- Mizutani Foundation for Glycoscience
- Israel Science Foundation
- Israel Academy of Sciences and Humanities
- Israel Cancer Research Fund
- Association for International Cancer Research
This publication has 30 references indexed in Scilit:
- Expression of Heparanase in Normal, Dysplastic, and Neoplastic Human Colonic Mucosa and StromaThe American Journal of Pathology, 2000
- Heparanase, a potential regulator of cell–matrix interactionsTrends in Biochemical Sciences, 2000
- Cloning and Functional Expression of a Human Heparanase GeneBiochemical and Biophysical Research Communications, 1999
- Functions of Cell Surface Heparan Sulfate ProteoglycansAnnual Review of Biochemistry, 1999
- Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound.Journal of Clinical Investigation, 1997
- Identification of multiple active growth factors in basement membrane matrigel suggests caution in interpretation of cellular activity related to extracellular matrix componentsExperimental Cell Research, 1992
- Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrixBiochemistry, 1992
- Heparanase activity in cultured endothelial cellsJournal of Cellular Physiology, 1991
- Heparanases and tumor metastasisJournal of Cellular Biochemistry, 1988
- Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour‐cell‐derived heparanasesInternational Journal of Cancer, 1987